30 January 2026 : Review article
Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A Review
Yuxia Zuo BCE 1, Xingchao Xu BC 2, Cai Wu E 2, Xue Cui CE 2, Xiangqi Li A 2*DOI: 10.12659/MSM.951283
Med Sci Monit 2026; 32:e951283
Table 3 Comparison of diagnostic performance between MSUS and MRI in evaluating chemotherapy-induced peripheral neuropathy (CIPN).
| Comparison dimension | Musculoskeletal ultrasound (MSUS) | Magnetic resonance imaging (MRI) |
|---|---|---|
| Diagnostic sensitivity | High detection rate for acute edema in superficial nerves (median nerve, ulnar nerve) | High detection rate for microstructural damage in deep nerves (sciatic nerve, sacral plexus) |
| Resolution and penetration depth | High-frequency probe (10–18 MHz): resolution of 0.1 mm, penetration depth <3 cm; Low-frequency probe: penetration depth up to 5 cm, resolution reduced to 0.3 mm | 3.0T equipment: resolution of nerve fascicles is 0.2 mm, penetration depth >10 cm, but insufficient resolution for distal nerves with diameter <2 mm (eg, interphalangeal/interdigital nerves) |
| Clinical applicability | Suitable for bedside rapid screening (5-10 minutes per examination) and dynamic monitoring during chemotherapy cycles | Suitable for pre-treatment baseline assessment and localization of deep nerves; single examination takes 15–20 minutes, and patients need to remain still during the examination |
| MSUS – musculoskeletal ultrasound; MRI – magnetic resonance imaging; CIPN – chemotherapy-induced peripheral neuropathy. | ||






